Author： Hawkins David Evans Jeffrey
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.4, Iss.3, 2005-05, pp. : 583-590
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Heparin-Induced Thrombocytopenia: Minimising the Risks in the Elderly Patient
Drugs & Aging, Vol. 16, Iss. 5, 2000-05 ,pp. :
Access to resources
Recommend
Benefit-Risk Assessment of Treatments for Heparin-Induced Thrombocytopenia
Drug Safety, Vol. 26, Iss. 9, 2003-01 ,pp. :
Pharmacotherapy of heparin-induced thrombocytopenia
By Dager William E White Richard H
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. :
Management of heparin-induced thrombocytopenia
By Jaax Miriam E. Greinacher Andreas
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. :